Osalmid

柳胺酚

Report date: 2023/03/16 20:00:26
NME

Base Information

Drug NameOsalmid
Drug Alias Nameosalmidum利胆酚osalmideosalmidaSaryuurin +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCholecystitisGallstonesCholestasis +[4] 
Global Approved IndicationsCholecystitisGallstones
Approved Indications in ChinaCholecystitisGallstones
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Tasly Diyi Pharmaceutical Co Ltd
Inactive CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Active IndicationsCholecystitisGallstonesCholestasis
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeA05A
Related LinksKEGG